Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Women'S Health (London, England)
|
October 7, 2009
Current and future developments in screening for ovarian cancer
Nicole Urban, Charles Drescher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma
Martin W McIntosh, Yan Liu, Charles Drescher, et al.
Cancer
|
October 26, 2005
Clinical trials: understanding and perceptions of female Chinese-American cancer patients
Shin-Ping Tu, Hueifang Chen, Anthony Chen, et al.
Molecular Imaging and Biology
|
July 5, 2007
2-deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines
A M Lutz, P Ray, J K Willmann, et al.
Gynecologic Oncology
|
May 9, 2012
Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling
Gaia Pocobelli, Jessica Chubak, Nancy Hanson, et al.
Gynecologic Oncology
|
December 14, 2011
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
Michèl Schummer, Charles Drescher, Robin Forrest, et al.
Cancer Biology & Therapy
|
November 21, 2020
Desmoglein-2 as a prognostic and biomarker in ovarian cancer
Jiho Kim, Peter Beidler, Hongjie Wang, et al.
Cancer Research
|
July 4, 2003
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, et al.
Cancer Biology & Therapy
|
August 31, 2016
Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells
Kamola Saydaminova, Robert Strauss, Min Xie, et al.
Plos One
|
June 19, 2010
Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer
Lynn M Amon, Wendy Law, Matthew P Fitzgibbon, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Women'S Health (London, England)
|
October 7, 2009
Current and future developments in screening for ovarian cancer
Nicole Urban, Charles Drescher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma
Martin W McIntosh, Yan Liu, Charles Drescher, et al.
Cancer
|
October 26, 2005
Clinical trials: understanding and perceptions of female Chinese-American cancer patients
Shin-Ping Tu, Hueifang Chen, Anthony Chen, et al.
Molecular Imaging and Biology
|
July 5, 2007
2-deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines
A M Lutz, P Ray, J K Willmann, et al.
Gynecologic Oncology
|
May 9, 2012
Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling
Gaia Pocobelli, Jessica Chubak, Nancy Hanson, et al.
Gynecologic Oncology
|
December 14, 2011
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
Michèl Schummer, Charles Drescher, Robin Forrest, et al.
Cancer Biology & Therapy
|
November 21, 2020
Desmoglein-2 as a prognostic and biomarker in ovarian cancer
Jiho Kim, Peter Beidler, Hongjie Wang, et al.
Cancer Research
|
July 4, 2003
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, et al.
Cancer Biology & Therapy
|
August 31, 2016
Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells
Kamola Saydaminova, Robert Strauss, Min Xie, et al.
Plos One
|
June 19, 2010
Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer
Lynn M Amon, Wendy Law, Matthew P Fitzgibbon, et al.
Page
of 3